Literature DB >> 16547780

Clinically important differences in Q-TWIST - one twist too many?

Richard Stephens1.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16547780     DOI： 10.1007/s11136-005-4672-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN： 0962-9343            Impact factor:   4.147


× No keyword cloud information.
  10 in total

1.  Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.

Authors:  E F Juniper; G H Guyatt; R S Epstein; P J Ferrie; R Jaeschke; T K Hiller
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

2.  Measurement of health status. Ascertaining the minimal clinically important difference.

Authors:  R Jaeschke; J Singer; G H Guyatt
Journal:  Control Clin Trials       Date:  1989-12

Review 3.  Interpretation of quality of life changes.

Authors:  E Lydick; R S Epstein
Journal:  Qual Life Res       Date:  1993-06       Impact factor: 4.147

4.  Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; A Willan; L E Griffith
Journal:  J Clin Epidemiol       Date:  1994-01       Impact factor: 6.437

5.  Interpreting the significance of changes in health-related quality-of-life scores.

Authors:  D Osoba; G Rodrigues; J Myles; B Zee; J Pater
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Defining the clinically important difference in pain outcome measures.

Authors:  J T Farrar; R K Portenoy; J A Berlin; J L Kinman; B L Strom
Journal:  Pain       Date:  2000-12-01       Impact factor: 6.961

7.  A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.

Authors:  R D Gelber; A Goldhirsch
Journal:  J Clin Oncol       Date:  1986-12       Impact factor: 44.544

8.  Parameter estimates for a QALY utility model.

Authors:  J M Miyamoto; S A Eraker
Journal:  Med Decis Making       Date:  1985       Impact factor: 2.583

9.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

Review 10.  Analyzing oncology clinical trial data using the Q-TWiST method: clinical importance and sources for health state preference data.

Authors:  Dennis A Revicki; David Feeny; Timothy L Hunt; Bernard F Cole
Journal:  Qual Life Res       Date:  2006-04       Impact factor: 4.147
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.